1,2-dimethylhydrazine decreases expression ISO RGD:1318385 6480464 1, 2-Dimethylhydrazine results in decreased expression of DHX9 mRNA CTD PMID:22206623 1-chloro-2,4-dinitrobenzene increases metabolic processing ISO RGD:1318384 6480464 Dinitrochlorobenzene results in increased metabolism of DHX9 protein CTD PMID:29267982 1-chloro-2,4-dinitrobenzene affects binding ISO RGD:1318384 6480464 Dinitrochlorobenzene binds to DHX9 protein CTD PMID:32991956 17beta-estradiol increases expression ISO RGD:1318384 6480464 Estradiol results in increased expression of DHX9 mRNA CTD PMID:16514628 17beta-estradiol multiple interactions ISO RGD:1318384 6480464 [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of DHX9 mRNA CTD PMID:20823114 2,2',5,5'-tetrachlorobiphenyl decreases expression EXP 6480464 2 more ... CTD PMID:23829299 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1318385 6480464 Tetrachlorodibenzodioxin affects the expression of DHX9 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of DHX9 mRNA CTD PMID:33387578 2-methylcholine affects expression ISO RGD:1318384 6480464 beta-methylcholine affects the expression of DHX9 mRNA CTD PMID:21179406 3',5'-cyclic UMP affects binding ISO RGD:1318384 6480464 DHX9 protein binds to cyclic 3', 5'-uridine monophosphate CTD PMID:30528433 3,4-methylenedioxymethamphetamine decreases expression ISO RGD:1318385 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of DHX9 mRNA CTD PMID:26251327 3H-1,2-dithiole-3-thione decreases expression EXP 6480464 1, 2-dithiol-3-thione results in decreased expression of DHX9 mRNA CTD PMID:19162173 4,4'-sulfonyldiphenol increases methylation ISO RGD:1318384 6480464 bis(4-hydroxyphenyl)sulfone results in increased methylation of DHX9 gene CTD PMID:31601247 4,4'-sulfonyldiphenol increases expression ISO RGD:1318384 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of DHX9 protein CTD PMID:34186270 4-vinylcyclohexene dioxide affects expression ISO RGD:1318385 6480464 4-vinyl-1-cyclohexene dioxide affects the expression of DHX9 mRNA CTD PMID:20829426 5-azacytidine decreases expression ISO RGD:1318384 6480464 Azacitidine results in decreased expression of DHX9 mRNA CTD PMID:20823114 acrolein multiple interactions ISO RGD:1318384 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of DHX9 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of DHX9 mRNA CTD PMID:32699268 afimoxifene decreases expression ISO RGD:1318384 6480464 afimoxifene results in decreased expression of DHX9 mRNA CTD PMID:16514628 aflatoxin B1 increases expression ISO RGD:1318385 6480464 Aflatoxin B1 results in increased expression of DHX9 mRNA CTD PMID:19770486 aflatoxin B1 increases methylation ISO RGD:1318384 6480464 Aflatoxin B1 results in increased methylation of DHX9 gene CTD PMID:27153756 alpha-pinene multiple interactions ISO RGD:1318384 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of DHX9 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of DHX9 mRNA CTD PMID:32699268 AM-251 decreases expression ISO RGD:1318384 6480464 AM 251 results in decreased expression of DHX9 mRNA CTD PMID:16500647 arsenous acid multiple interactions ISO RGD:1318385 6480464 Metformin inhibits the reaction [Arsenic Trioxide results in increased expression of DHX9 mRNA] CTD PMID:29095437 arsenous acid increases expression ISO RGD:1318385 6480464 Arsenic Trioxide results in increased expression of DHX9 mRNA CTD PMID:29095437 atrazine decreases expression ISO RGD:1318384 6480464 Atrazine results in decreased expression of DHX9 mRNA CTD PMID:22378314 benzene decreases expression ISO RGD:1318385 6480464 Benzene results in decreased expression of DHX9 mRNA CTD PMID:15120971 benzo[a]pyrene increases expression ISO RGD:1318385 6480464 Benzo(a)pyrene results in increased expression of DHX9 mRNA CTD PMID:19770486 , PMID:22228805 benzo[a]pyrene increases methylation ISO RGD:1318384 6480464 Benzo(a)pyrene results in increased methylation of DHX9 5' UTR CTD PMID:27901495 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1318384 6480464 7 more ... CTD PMID:20018196 benzo[a]pyrene diol epoxide I increases expression ISO RGD:1318384 6480464 7 more ... CTD PMID:26238291 bisphenol A decreases expression ISO RGD:1318385 6480464 bisphenol A results in decreased expression of DHX9 mRNA CTD PMID:26063408 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of DHX9 mRNA CTD PMID:34947998 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of DHX9 mRNA CTD PMID:25181051 bisphenol F increases expression ISO RGD:1318384 6480464 bisphenol F results in increased expression of DHX9 protein CTD PMID:34186270 bucladesine multiple interactions ISO RGD:1318384 6480464 [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of DHX9 mRNA CTD PMID:20823114 cadmium dichloride decreases expression ISO RGD:1318385 6480464 Cadmium Chloride results in decreased expression of DHX9 mRNA CTD PMID:24982889 CGP 52608 multiple interactions ISO RGD:1318384 6480464 CGP 52608 promotes the reaction [RORA protein binds to DHX9 gene] CTD PMID:28238834 chloromethylisothiazolinone increases metabolic processing ISO RGD:1318384 6480464 5-chloro-2-methyl-4-isothiazolin-3-one results in increased metabolism of DHX9 protein CTD PMID:29267982 cobalt dichloride decreases expression ISO RGD:1318384 6480464 cobaltous chloride results in decreased expression of DHX9 mRNA CTD PMID:19320972 copper atom multiple interactions ISO RGD:1318384 6480464 [NSC 689534 binds to Copper] which results in decreased expression of DHX9 mRNA CTD PMID:20971185 copper(0) multiple interactions ISO RGD:1318384 6480464 [NSC 689534 binds to Copper] which results in decreased expression of DHX9 mRNA CTD PMID:20971185 cyclosporin A decreases expression ISO RGD:1318384 6480464 Cyclosporine results in decreased expression of DHX9 mRNA CTD PMID:25562108 diarsenic trioxide increases expression ISO RGD:1318385 6480464 Arsenic Trioxide results in increased expression of DHX9 mRNA CTD PMID:29095437 diarsenic trioxide multiple interactions ISO RGD:1318385 6480464 Metformin inhibits the reaction [Arsenic Trioxide results in increased expression of DHX9 mRNA] CTD PMID:29095437 dorsomorphin multiple interactions ISO RGD:1318384 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DHX9 mRNA CTD PMID:27188386 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of DHX9 mRNA CTD PMID:29391264 enzyme inhibitor multiple interactions ISO RGD:1318384 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of DHX9 protein CTD PMID:23301498 ethanol multiple interactions ISO RGD:1318385 6480464 Ethanol affects the expression of and affects the splicing of DHX9 mRNA CTD PMID:30319688 ethyl methanesulfonate decreases expression ISO RGD:1318384 6480464 Ethyl Methanesulfonate results in decreased expression of DHX9 mRNA CTD PMID:23649840 flutamide increases expression EXP 6480464 Flutamide results in increased expression of DHX9 mRNA CTD PMID:24136188 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of DHX9 mRNA CTD PMID:24793618 fulvestrant decreases expression ISO RGD:1318384 6480464 fulvestrant results in decreased expression of DHX9 mRNA CTD PMID:16514628 geldanamycin increases expression ISO RGD:1318384 6480464 geldanamycin results in increased expression of DHX9 mRNA CTD PMID:26705709 gemcitabine decreases expression ISO RGD:1318384 6480464 Gemcitabine results in decreased expression of DHX9 mRNA CTD PMID:17039268 genistein increases expression ISO RGD:1318385 6480464 Genistein results in increased expression of DHX9 mRNA CTD PMID:32186404 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of DHX9 mRNA CTD PMID:22061828 glycidol decreases expression EXP 6480464 glycidol results in decreased expression of DHX9 mRNA CTD PMID:24395379 hydrogen peroxide affects expression ISO RGD:1318384 6480464 Hydrogen Peroxide affects the expression of DHX9 mRNA CTD PMID:20044591 indole-3-methanol affects expression EXP 6480464 indole-3-carbinol affects the expression of DHX9 mRNA CTD PMID:21396975 ivermectin decreases expression ISO RGD:1318384 6480464 Ivermectin results in decreased expression of DHX9 protein CTD PMID:32959892 lead(0) affects expression ISO RGD:1318384 6480464 Lead affects the expression of DHX9 mRNA CTD PMID:28903495 lead(2+) affects expression ISO RGD:1318384 6480464 Lead affects the expression of DHX9 mRNA CTD PMID:28903495 leflunomide increases expression EXP 6480464 leflunomide results in increased expression of DHX9 mRNA CTD PMID:24136188 medroxyprogesterone acetate multiple interactions ISO RGD:1318384 6480464 [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of DHX9 mRNA CTD PMID:20823114 menadione affects expression ISO RGD:1318384 6480464 Vitamin K 3 affects the expression of DHX9 mRNA CTD PMID:20044591 metformin multiple interactions ISO RGD:1318385 6480464 Metformin inhibits the reaction [Arsenic Trioxide results in increased expression of DHX9 mRNA] CTD PMID:29095437 methoxychlor affects expression ISO RGD:1318385 6480464 Methoxychlor affects the expression of DHX9 mRNA CTD PMID:20829426 methylmercury chloride increases expression ISO RGD:1318384 6480464 methylmercuric chloride results in increased expression of DHX9 mRNA CTD PMID:26272509 methylparaben increases expression ISO RGD:1318384 6480464 methylparaben results in increased expression of DHX9 mRNA CTD PMID:31745603 N-methyl-4-phenylpyridinium increases expression ISO RGD:1318385 6480464 1-Methyl-4-phenylpyridinium results in increased expression of DHX9 protein CTD PMID:26558463 ozone multiple interactions ISO RGD:1318384 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of DHX9 mRNA more ... CTD PMID:32699268 paracetamol affects expression ISO RGD:1318385 6480464 Acetaminophen affects the expression of DHX9 mRNA CTD PMID:17562736 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of DHX9 mRNA CTD PMID:33387578 PCB138 increases expression EXP 6480464 2 more ... CTD PMID:23829299 pentachlorophenol increases expression ISO RGD:1318385 6480464 Pentachlorophenol results in increased expression of DHX9 mRNA CTD PMID:23892564 phenytoin increases expression EXP 6480464 Phenytoin results in increased expression of DHX9 mRNA CTD PMID:20345932 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of DHX9 mRNA CTD PMID:19162173 piroxicam decreases expression ISO RGD:1318384 6480464 Piroxicam results in decreased expression of DHX9 mRNA CTD PMID:21858171 raloxifene decreases expression ISO RGD:1318384 6480464 Raloxifene Hydrochloride results in decreased expression of DHX9 mRNA CTD PMID:16514628 resveratrol decreases expression ISO RGD:1318385 6480464 resveratrol results in decreased expression of DHX9 protein CTD PMID:25505154 resveratrol multiple interactions ISO RGD:1318384 6480464 [Plant Extracts co-treated with Resveratrol] results in increased expression of DHX9 mRNA CTD PMID:23557933 resveratrol decreases expression EXP 6480464 resveratrol results in decreased expression of DHX9 mRNA CTD PMID:25905778 SB 431542 multiple interactions ISO RGD:1318384 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DHX9 mRNA CTD PMID:27188386 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of DHX9 protein CTD PMID:29459688 sodium arsenite increases expression ISO RGD:1318384 6480464 sodium arsenite results in increased expression of DHX9 mRNA CTD PMID:34032870 succimer multiple interactions ISO RGD:1318385 6480464 [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of DHX9 mRNA CTD PMID:21641980 tert-butyl hydroperoxide decreases expression ISO RGD:1318384 6480464 tert-Butylhydroperoxide results in decreased expression of DHX9 mRNA CTD PMID:15336504 Testosterone propionate decreases expression ISO RGD:1318385 6480464 Testosterone Propionate results in decreased expression of DHX9 mRNA CTD PMID:15601916 tetrachloromethane increases expression ISO RGD:1318385 6480464 Carbon Tetrachloride results in increased expression of DHX9 mRNA CTD PMID:31919559 thapsigargin increases expression ISO RGD:1318385 6480464 Thapsigargin results in increased expression of DHX9 protein CTD PMID:24648495 thimerosal decreases expression ISO RGD:1318384 6480464 Thimerosal results in decreased expression of DHX9 mRNA CTD PMID:27188386 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of DHX9 mRNA CTD PMID:34492290 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of DHX9 mRNA CTD PMID:33387578 trichostatin A decreases expression ISO RGD:1318384 6480464 trichostatin A results in decreased expression of DHX9 mRNA CTD PMID:26272509 trichostatin A multiple interactions ISO RGD:1318384 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DHX9 mRNA CTD PMID:27188386 troglitazone decreases expression ISO RGD:1318385 6480464 troglitazone results in decreased expression of DHX9 mRNA CTD PMID:28973697 tunicamycin decreases expression ISO RGD:1318384 6480464 Tunicamycin results in decreased expression of DHX9 mRNA CTD PMID:22378314 ursodeoxycholic acid affects expression ISO RGD:1318384 6480464 Ursodeoxycholic Acid affects the expression of DHX9 mRNA CTD PMID:18422935 valproic acid increases methylation ISO RGD:1318384 6480464 Valproic Acid results in increased methylation of DHX9 gene CTD PMID:29154799 valproic acid decreases expression ISO RGD:1318384 6480464 Valproic Acid results in decreased expression of DHX9 mRNA CTD PMID:23179753 , PMID:27188386 vitamin E decreases expression ISO RGD:1318384 6480464 Vitamin E results in decreased expression of DHX9 mRNA CTD PMID:19244175 vorinostat decreases expression ISO RGD:1318384 6480464 vorinostat results in decreased expression of DHX9 mRNA CTD PMID:27188386